人工知能（AI）による創薬市場規模、シェア、競合情勢、トレンド分析レポート：タイプ別（前臨床試験、臨床試験、分子スクリーニング、標的同定、デノボ医薬品設計、医薬品最適化）、用途別（神経学、感染症、腫瘍学、その他）、薬物タイプ別（低分子、大分子）、オファリング別（ソフトウェア、サービス）、技術別（機械学習、その他）、 薬物タイプ別（低分子、高分子）、技術別（機械学習、その他）、エンドユーザー別（製薬およびバイオテクノロジー企業、契約研究機関、学術および研究、その他）： 2024 年から 2032 年までの機会分析と業界予測
レポートID : ROJP0624168 |
発行日 : 2024年06月 |
フォーマット : 
: 
: 
無料サンプル
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. End User Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Artificial Intelligence (AI) In Drug Discovery Market
5.1. COVID-19 Landscape: Artificial Intelligence (AI) In Drug Discovery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Artificial Intelligence (AI) In Drug Discovery Market, By Type
8.1. Artificial Intelligence (AI) In Drug Discovery Market, by Type, 2024-2033
8.1.1. Preclinical and Clinical Testing
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Molecule Screening
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Target Identification
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. De Novo Drug Design and Drug Optimization
8.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Artificial Intelligence (AI) In Drug Discovery Market, By Application
9.1. Artificial Intelligence (AI) In Drug Discovery Market, by Application, 2024-2033
9.1.1. Neurology
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Infectious Disease
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Artificial Intelligence (AI) In Drug Discovery Market, By Drug Type
10.1. Artificial Intelligence (AI) In Drug Discovery Market, by Drug Type, 2024-2033
10.1.1. Small Molecules
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Large Molecules
10.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Artificial Intelligence (AI) In Drug Discovery Market, By Offering
11.1. Artificial Intelligence (AI) In Drug Discovery Market, by Offering, 2024-2033
11.1.1. Software
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Services
11.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Artificial Intelligence (AI) In Drug Discovery Market, By Technology
12.1. Artificial Intelligence (AI) In Drug Discovery Market, by Technology, 2024-2033
12.1.1. Machine Learning
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Other Technologies
12.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 13. Global Artificial Intelligence (AI) In Drug Discovery Market, By End User
13.1. Artificial Intelligence (AI) In Drug Discovery Market, by End User, 2024-2033
13.1.1. Pharmaceutical & Biotechnology Companies
13.1.1.1. Market Revenue and Forecast (2021-2033)
13.1.2. Contract Research Organizations
13.1.2.1. Market Revenue and Forecast (2021-2033)
13.1.3. Academics & Research
13.1.3.1. Market Revenue and Forecast (2021-2033)
13.1.4. Others
13.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 14. Global Artificial Intelligence (AI) In Drug Discovery Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Type (2021-2033)
14.1.2. Market Revenue and Forecast, by Application (2021-2033)
14.1.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.1.4. Market Revenue and Forecast, by Offering (2021-2033)
14.1.5. Market Revenue and Forecast, by Technology (2021-2033)
14.1.6. Market Revenue and Forecast, by End User (2021-2033)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Type (2021-2033)
14.1.7.2. Market Revenue and Forecast, by Application (2021-2033)
14.1.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.1.7.4. Market Revenue and Forecast, by Offering (2021-2033)
14.1.8. Market Revenue and Forecast, by Technology (2021-2033)
14.1.8.1. Market Revenue and Forecast, by End User (2021-2033)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type (2021-2033)
14.1.9.2. Market Revenue and Forecast, by Application (2021-2033)
14.1.9.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.1.9.4. Market Revenue and Forecast, by Offering (2021-2033)
14.1.10. Market Revenue and Forecast, by Technology (2021-2033)
14.1.11. Market Revenue and Forecast, by End User (2021-2033)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.4. Market Revenue and Forecast, by Offering (2021-2033)
14.2.5. Market Revenue and Forecast, by Technology (2021-2033)
14.2.6. Market Revenue and Forecast, by End User (2021-2033)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.8.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.8.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.9. Market Revenue and Forecast, by Offering (2021-2033)
14.2.10. Market Revenue and Forecast, by Technology (2021-2033)
14.2.10.1. Market Revenue and Forecast, by End User (2021-2033)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.11.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.11.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.12. Market Revenue and Forecast, by Offering (2021-2033)
14.2.13. Market Revenue and Forecast, by Technology (2021-2033)
14.2.14. Market Revenue and Forecast, by End User (2021-2033)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.15.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.15.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.15.4. Market Revenue and Forecast, by Offering (2021-2033)
14.2.16. Market Revenue and Forecast, by Technology (2021-2033)
14.2.16.1. Market Revenue and Forecast, by End User (2021-2033)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.17.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.17.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.17.4. Market Revenue and Forecast, by Offering (2021-2033)
14.2.18. Market Revenue and Forecast, by Technology (2021-2033)
14.2.18.1. Market Revenue and Forecast, by End User (2021-2033)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.5. Market Revenue and Forecast, by Technology (2021-2033)
14.3.6. Market Revenue and Forecast, by End User (2021-2033)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.7.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.7.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.8. Market Revenue and Forecast, by Technology (2021-2033)
14.3.9. Market Revenue and Forecast, by End User (2021-2033)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.10.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.10.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.10.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.11. Market Revenue and Forecast, by Technology (2021-2033)
14.3.11.1. Market Revenue and Forecast, by End User (2021-2033)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.12.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.12.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.12.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.12.5. Market Revenue and Forecast, by Technology (2021-2033)
14.3.12.6. Market Revenue and Forecast, by End User (2021-2033)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.13.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.13.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.13.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.13.5. Market Revenue and Forecast, by Technology (2021-2033)
14.3.13.6. Market Revenue and Forecast, by End User (2021-2033)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.5. Market Revenue and Forecast, by Technology (2021-2033)
14.4.6. Market Revenue and Forecast, by End User (2021-2033)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.7.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.7.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.8. Market Revenue and Forecast, by Technology (2021-2033)
14.4.9. Market Revenue and Forecast, by End User (2021-2033)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.10.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.10.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.10.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.11. Market Revenue and Forecast, by Technology (2021-2033)
14.4.12. Market Revenue and Forecast, by End User (2021-2033)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.13.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.13.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.13.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.13.5. Market Revenue and Forecast, by Technology (2021-2033)
14.4.13.6. Market Revenue and Forecast, by End User (2021-2033)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.14.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.14.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.14.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.14.5. Market Revenue and Forecast, by Technology (2021-2033)
14.4.14.6. Market Revenue and Forecast, by End User (2021-2033)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type (2021-2033)
14.5.2. Market Revenue and Forecast, by Application (2021-2033)
14.5.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.5.4. Market Revenue and Forecast, by Offering (2021-2033)
14.5.5. Market Revenue and Forecast, by Technology (2021-2033)
14.5.6. Market Revenue and Forecast, by End User (2021-2033)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Type (2021-2033)
14.5.7.2. Market Revenue and Forecast, by Application (2021-2033)
14.5.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.5.7.4. Market Revenue and Forecast, by Offering (2021-2033)
14.5.8. Market Revenue and Forecast, by Technology (2021-2033)
14.5.8.1. Market Revenue and Forecast, by End User (2021-2033)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type (2021-2033)
14.5.9.2. Market Revenue and Forecast, by Application (2021-2033)
14.5.9.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.5.9.4. Market Revenue and Forecast, by Offering (2021-2033)
14.5.9.5. Market Revenue and Forecast, by Technology (2021-2033)
14.5.9.6. Market Revenue and Forecast, by End User (2021-2033)
Chapter 15. Company Profiles
15.1. NVIDIA CORPORATION
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Microsoft Corporation
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. INSILICO MEDICINE INC.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Schrödinger
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. EXSCIENTIA
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Cloud Pharmaceuticals
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. TOMWISE, INC
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
